A new framework called SkillWeaver tackles AI agent tool routing by skipping full-library loading, cutting token use 99% on ...

Your content may already be surfacing for searches you never planned for. Here's how to identify those opportunities and act ...

WHILE artificial intelligence (AI) is being touted as a solution to many data-related challenges, it cannot generate agricultural market intelligence without human involvement. The most important step ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Jon Gilbert is a Features Writer for Android Police. I've covered Android since 2021, focusing on writing features and guides about Android apps and features that directly affect users. I've attended ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...